
Oncologist

No OPD information available
Testicular Cancer
Ovarian Cancer
Prostate Cancer
Breast Cancer
Cervical Cancer
Endometrial Cancer
Lung Cancer
Mesothelioma
Non-Small Cell Lung Cancer (NSCLC)
Renal Cell Carcinoma (RCC)
Acute Pain
Bladder Cancer
Bone Tumor
Cervical Dysplasia
Colorectal Cancer
EGFR Positive Lung Cancer
Esophageal Cancer
Febrile Neutropenia
HER-2 Positive Breast Cancer
Hypogonadism
Lung Metastases
Lymphofollicular Hyperplasia
Melanoma
Metabolic Syndrome
Nephrectomy
Orchiectomy
Prostatectomy
Stomach Cancer
Martin R. Stockler is a male healthcare provider who helps patients with various types of cancer like testicular, ovarian, prostate, breast, cervical, and lung cancer, among others. He also treats conditions like acute pain, hypogonadism, metabolic syndrome, and performs surgeries like nephrectomy, orchiectomy, and prostatectomy.
Patients trust Martin R. Stockler because he communicates well with them, listens to their concerns, and explains things clearly. He stays updated with the latest medical knowledge and research to provide the best care possible. He works closely with other medical professionals to ensure comprehensive treatment for his patients.
One of his notable publications is about using machine learning to predict fast progression in lung cancer patients receiving certain treatments. He is also involved in a clinical trial testing a new therapy for metastatic prostate cancer.
Martin R. Stockler's work has positively impacted many patients' lives by providing effective treatments, managing symptoms, and improving their quality of life. Patients appreciate his dedication, expertise, and compassionate approach to care.
In summary, Martin R. Stockler is a skilled and compassionate healthcare provider who specializes in treating various types of cancer and related conditions. He stays updated with the latest research, collaborates with other medical professionals, and has made a positive impact on many patients' lives through his expertise and care.
Enrollment Status: Active not recruiting
Published: February 06, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
